CALR and Thrombocytosis: Although allele burden in CALR-mutated patients often tends to be close to 50% when disease declare, it would be interesting to compare platelet levels in del52 and ins5 ETs with similar and low allele burden and to follow progression of thrombocytosis to measure the real impact of these two mutations on platelet counts.